190 related articles for article (PubMed ID: 1479719)
21. [Prophylactic effect of ulinastatin on cisplatin-induced renal disorders in lung cancer patients].
Horiguchi T; Kasahara J; Ogura K; Handa M; Hosoda H; Shakato A; Tachikawa S; Sato M; Suetsugu S; Umeda H
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):12-9. PubMed ID: 1625386
[TBL] [Abstract][Full Text] [Related]
22. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
[TBL] [Abstract][Full Text] [Related]
23. [Preventive effect of prostaglandin E1 on cisplatin-induced nephrotoxicity].
Takayama K; Nakanishi Y; Takano K; Harada T; Inoue K; Osaki S; Minami T; Hara N
Gan To Kagaku Ryoho; 1999 Mar; 26(4):503-8. PubMed ID: 10097747
[TBL] [Abstract][Full Text] [Related]
24. [The effect of bismuth subnitrate on cisplatin toxicity].
Chen JT; Kurokawa Y; Nakayama K; Saito K; Sakamoto K; Fukuda K; Hirai Y; Hamada T; Fujimoto I; Yamauchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):815-22. PubMed ID: 3298471
[TBL] [Abstract][Full Text] [Related]
25. [Acute change in urinary NAG activity following CDDP administration].
Yoshida K; Takahashi T; Nakame Y; Saitoh H; Horiuchi S; Kaneoya F; Negishi T
Hinyokika Kiyo; 1986 Mar; 32(3):369-73. PubMed ID: 3728241
[TBL] [Abstract][Full Text] [Related]
26. [NAG (N-acetyl-beta-D-glucosaminidase)--a sensitive marker for disorders of kidney function].
Skrezek C; Bertermann H; Schulz FP; König B
Urologe A; 1990 Jan; 29(1):27-31. PubMed ID: 2316078
[TBL] [Abstract][Full Text] [Related]
27. [Renal tubular impairment in traumatized patients].
Yokota J; Sakamoto T; Uenishi M; Shibuya M; Hashimoto K; Yoshioka T; Sugimoto T
Nihon Geka Gakkai Zasshi; 1986 Nov; 87(11):1391-7. PubMed ID: 3537681
[TBL] [Abstract][Full Text] [Related]
28. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
[TBL] [Abstract][Full Text] [Related]
29. [High sensitive photometric assay of pancreatic lipase and clinical investigation of urinary lipase in patients with various histopathological types of primary glomerulonephritis].
Soezima A; Yomogida S; Suzuki M; Tuzi M; Nakabayasi K; Kitamoto K; Nagasawa T
Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1103-7. PubMed ID: 2287102
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin nephrotoxicity and protection by silibinin.
Gaedeke J; Fels LM; Bokemeyer C; Mengs U; Stolte H; Lentzen H
Nephrol Dial Transplant; 1996 Jan; 11(1):55-62. PubMed ID: 8649653
[TBL] [Abstract][Full Text] [Related]
31. [The pharmacokinetics of cisplatin and its influence on renal function according to different infusion methods (report II)--alleviation of renal impairment by bismuth subnitrate combined with ginseng and tang-koui ten].
Takahashi A; Takagi M; Hishida H; Sakamoto Y; Takagi N; Amano H; Ogura Y
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2405-10. PubMed ID: 2665654
[TBL] [Abstract][Full Text] [Related]
32. Direct amifostine effect on renal tubule cells in rats.
Weichert-Jacobsen KJ; Bannowski A; Küppers F; Loch T; Stöckle M
Cancer Res; 1999 Jul; 59(14):3451-3. PubMed ID: 10416609
[TBL] [Abstract][Full Text] [Related]
33. Clinical value of fructose 1,6 bisphosphatase in monitoring renal proximal tubular injury.
Pfaller W; Thorwartl U; Nevinny-Stickel M; Krall M; Schober M; Joannidis M; Hobisch A
Kidney Int Suppl; 1994 Nov; 47():S68-75. PubMed ID: 7532742
[TBL] [Abstract][Full Text] [Related]
34. Renal tubular function in patients treated with high-dose cisplatin.
Daugaard G; Abildgaard U; Holstein-Rathlou NH; Bruunshuus I; Bucher D; Leyssac PP
Clin Pharmacol Ther; 1988 Aug; 44(2):164-72. PubMed ID: 2840230
[TBL] [Abstract][Full Text] [Related]
35. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model].
Ali-Miraftab H; Bourbouze R; Bondiou MT; Percheron F
Pathol Biol (Paris); 1988 Mar; 36(3):240-4. PubMed ID: 3283687
[TBL] [Abstract][Full Text] [Related]
36. [Studies of enzymuria and proteinuria: Report 2; Relationship between glomerular filtration rate and urinary enzymuria and proteinuria].
Yasumoto R; Tanaka S; Kawashima H; Kakinoki K; Iseki T; Umeda M; Tanabe S; Nishisaka N; Asakawa M
Hinyokika Kiyo; 1989 Jul; 35(7):1125-8. PubMed ID: 2478007
[TBL] [Abstract][Full Text] [Related]
37. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
[TBL] [Abstract][Full Text] [Related]
38. [A study on a postoperative change of beta-2-microglobulin in surgical patients].
Homma T; Tsujinaka T; Kido Y; Hayashida Y; Ishida H; Iijima S; Mori T
Nihon Geka Gakkai Zasshi; 1992 May; 93(5):455-61. PubMed ID: 1614390
[TBL] [Abstract][Full Text] [Related]
39. [Studies on protective effect of selenium on the nephrotoxicity of cis-diamminedichloroplatinum (CDDP) in mice].
Araya Y
Hokkaido Igaku Zasshi; 1990 May; 65(3):245-53. PubMed ID: 2165995
[TBL] [Abstract][Full Text] [Related]
40. Renal tubular function in children with beta-thalassemia minor.
Kalman S; Atay AA; Sakallioglu O; Ozgürtaş T; Gök F; Kurt I; Kürekçi AE; Ozcan O; Gökçay E
Nephrology (Carlton); 2005 Oct; 10(5):427-9. PubMed ID: 16221088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
